76.00USD+0.82%Mkt Cap: 2.63B $P/E: 17.391d ago
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap2.63B $
Enterprise Value3.01B $
Revenue (TTM)635.89M $
Gross Profit362.81M $
Net Income (TTM)190.29M $
Revenue/Share18.62 USD
Last Price76.00 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees898
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)17.39
P/E (Forward)27.48
PEG—
EV/EBITDA23.99
EV/Revenue4.73
P/S4.13
P/B5.31
EPS (TTM)4.37
EPS (Forward)2.77
52W Range
60.1017% of range156.00
52W High156.00 USD
52W Low60.10 USD
Profitability
Gross Margin59.92%
Oper. Margin7.65%
EBITDA Margin19.71%
Profit Margin31.43%
ROE40.22%
ROA17.81%
Growth
Revenue Growth21.20%
Earnings Growth-71.50%
Cash Flow & Leverage
Operating CF192.84M $
CapEx (TTM)59.25M $
FCF Margin17.11%
FCF Yield4.14%
Net Debt401.68M $
Net Debt/EBITDA3.20
Balance Sheet
Debt/Equity1.10
Current Ratio6.74
Quick Ratio6.01
Book Value/Sh14.30 USD
Cash/Share13.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)114.00 USD
Upside (mean)+50.0%
Target Range80.00 USD – 142.00 USD
$80.00+50.0% to mean$142.00
# Analysts9
Ownership
Shares Out.34.56M
Float33.43M
Insiders3.51%
Institutions109.53%
Short Interest
Short Ratio6.6d
Short % Float35.50%
Short % Out.22.76%
Shares Short7.87M
Short (prev mo.)7.36M
Technical
SMA 5071.62 (+6.1%)
SMA 200111.47 (-31.8%)
Beta1.88
S&P 52W Chg20.25%
Avg Vol (30d)1.03M
Avg Vol (10d)819.52K
Technical Indicators
RSI (14)55.2
MACD-0.0664
MACD Signal-0.9117
MACD Hist.+0.8453
BB Upper80.45 USD
BB Middle72.94 USD
BB Lower65.43 USD
BB Width20.59%
ATR (14)4.041 USD
Vol Ratio (20d)0.68x